| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8757535 | Contemporary Clinical Trials | 2018 | 22 Pages |
Abstract
With its completion, the VA Comparative Effectiveness in Gout: Allopurinol vs Febuxostat study will demonstrate the central role of gradual ULT dose escalation and a treat-to-target strategy in gout management.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Timilsina S., Brittan K., O'Dell J.R., Brophy M., Davis-Karim A., Henrie A.M., Neogi T., Newcomb J., Palevsky P.M., Pillinger M.H., Pittman D., Taylor T.H., Wu H., Mikuls T.R.,